The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma
Background/purpose: Myeloma jaw lesions are not uncommon. The study aimed to investigate the status of jaw lesions and medication-related osteonecrosis of jaw (MRONJ) in multiple myeloma (MM) patients. Methods: One hundred and twenty-two consecutive newly-diagnosed MM patients seeking dental care at...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-11-01
|
| Series: | Journal of the Formosan Medical Association |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664621000371 |
| _version_ | 1818899747401891840 |
|---|---|
| author | Shin-Yu Lu Ming-Chun Ma Ming-Chung Wang Shui-Sang Hsue |
| author_facet | Shin-Yu Lu Ming-Chun Ma Ming-Chung Wang Shui-Sang Hsue |
| author_sort | Shin-Yu Lu |
| collection | DOAJ |
| description | Background/purpose: Myeloma jaw lesions are not uncommon. The study aimed to investigate the status of jaw lesions and medication-related osteonecrosis of jaw (MRONJ) in multiple myeloma (MM) patients. Methods: One hundred and twenty-two consecutive newly-diagnosed MM patients seeking dental care at a hospital of southern Taiwan was examined according to jaw lesions with complete follow-up data. Results: Median age of the patients was 67.8 years, and 88.5% of patients were of DS stage III and 41.0% were of ISS stage III at diagnosis. Median survival was 37.9 months for 43 (35.2%) patients with jaw lesions and 57.4 months for 79 patients without jaw lesions. 1-year, 5-year and >7-year overall survival rates for patients with jaw lesions versus patients without jaw lesions were 94.9%, 67.2%, 56.7% vs 83.7%, 51.8%, 26.8% respectively. Patients with jaw lesions had the worse survival (P = 0.03). Neither age nor stage affected survival. Jaw lesions involved the mandible more often than the maxilla and stopped progressing during remission, but did not repair. Jaw lesions were the first evidence or recurrent sign of MM in six (4.9%) patients. Long-term monthly antiresorptive therapy changed the radiographic patterns of jawbones and induced MRONJ developing in 16.7% (8/48) of patients. Five (62.5%) MRONJ sites spontaneously occurred without local risk factors. Conclusion: Nearly one-third of MM patients develop osteolytic jaw lesions that seem to be associated with poorer survival. Jaw lesion is an independent prognostic predictor of survival in myeloma. Antiresorptive drugs at less frequent dosing regimen are crucial to minimize spontaneous MRONJ. |
| first_indexed | 2024-12-19T19:52:53Z |
| format | Article |
| id | doaj.art-34701c9e42594a1180e62bf1703e0a34 |
| institution | Directory Open Access Journal |
| issn | 0929-6646 |
| language | English |
| last_indexed | 2024-12-19T19:52:53Z |
| publishDate | 2021-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of the Formosan Medical Association |
| spelling | doaj.art-34701c9e42594a1180e62bf1703e0a342022-12-21T20:07:53ZengElsevierJournal of the Formosan Medical Association0929-66462021-11-011201119671976The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myelomaShin-Yu Lu0Ming-Chun Ma1Ming-Chung Wang2Shui-Sang Hsue3Oral Pathology and Family Dentistry Section, Department of Dentistry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Corresponding author. Kaohsiung Chang Gung Memorial Hospital 123 Dapi Road, Niaosong District, Kaohsiung 833, Taiwan.Department of Hematology-Oncology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Hematology-Oncology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, TaiwanOral Pathology and Family Dentistry Section, Department of Dentistry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanBackground/purpose: Myeloma jaw lesions are not uncommon. The study aimed to investigate the status of jaw lesions and medication-related osteonecrosis of jaw (MRONJ) in multiple myeloma (MM) patients. Methods: One hundred and twenty-two consecutive newly-diagnosed MM patients seeking dental care at a hospital of southern Taiwan was examined according to jaw lesions with complete follow-up data. Results: Median age of the patients was 67.8 years, and 88.5% of patients were of DS stage III and 41.0% were of ISS stage III at diagnosis. Median survival was 37.9 months for 43 (35.2%) patients with jaw lesions and 57.4 months for 79 patients without jaw lesions. 1-year, 5-year and >7-year overall survival rates for patients with jaw lesions versus patients without jaw lesions were 94.9%, 67.2%, 56.7% vs 83.7%, 51.8%, 26.8% respectively. Patients with jaw lesions had the worse survival (P = 0.03). Neither age nor stage affected survival. Jaw lesions involved the mandible more often than the maxilla and stopped progressing during remission, but did not repair. Jaw lesions were the first evidence or recurrent sign of MM in six (4.9%) patients. Long-term monthly antiresorptive therapy changed the radiographic patterns of jawbones and induced MRONJ developing in 16.7% (8/48) of patients. Five (62.5%) MRONJ sites spontaneously occurred without local risk factors. Conclusion: Nearly one-third of MM patients develop osteolytic jaw lesions that seem to be associated with poorer survival. Jaw lesion is an independent prognostic predictor of survival in myeloma. Antiresorptive drugs at less frequent dosing regimen are crucial to minimize spontaneous MRONJ.http://www.sciencedirect.com/science/article/pii/S0929664621000371Multiple myelomaJaw lesionsMRONJ |
| spellingShingle | Shin-Yu Lu Ming-Chun Ma Ming-Chung Wang Shui-Sang Hsue The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma Journal of the Formosan Medical Association Multiple myeloma Jaw lesions MRONJ |
| title | The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma |
| title_full | The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma |
| title_fullStr | The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma |
| title_full_unstemmed | The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma |
| title_short | The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma |
| title_sort | status of jaw lesions and medication related osteonecrosis of jaw in patients with multiple myeloma |
| topic | Multiple myeloma Jaw lesions MRONJ |
| url | http://www.sciencedirect.com/science/article/pii/S0929664621000371 |
| work_keys_str_mv | AT shinyulu thestatusofjawlesionsandmedicationrelatedosteonecrosisofjawinpatientswithmultiplemyeloma AT mingchunma thestatusofjawlesionsandmedicationrelatedosteonecrosisofjawinpatientswithmultiplemyeloma AT mingchungwang thestatusofjawlesionsandmedicationrelatedosteonecrosisofjawinpatientswithmultiplemyeloma AT shuisanghsue thestatusofjawlesionsandmedicationrelatedosteonecrosisofjawinpatientswithmultiplemyeloma AT shinyulu statusofjawlesionsandmedicationrelatedosteonecrosisofjawinpatientswithmultiplemyeloma AT mingchunma statusofjawlesionsandmedicationrelatedosteonecrosisofjawinpatientswithmultiplemyeloma AT mingchungwang statusofjawlesionsandmedicationrelatedosteonecrosisofjawinpatientswithmultiplemyeloma AT shuisanghsue statusofjawlesionsandmedicationrelatedosteonecrosisofjawinpatientswithmultiplemyeloma |